A detailed history of Cwm, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, Cwm, LLC holds 650 shares of FGEN stock, worth $227. This represents 0.0% of its overall portfolio holdings.

Number of Shares
650
Previous 10,672 93.91%
Holding current value
$227
Previous $10,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$0.33 - $1.26 $3,307 - $12,627
-10,022 Reduced 93.91%
650 $0
Q2 2024

Jul 09, 2024

BUY
$0.89 - $2.36 $7,838 - $20,784
8,807 Added 472.23%
10,672 $10,000
Q1 2024

Apr 05, 2024

BUY
$0.73 - $2.73 $570 - $2,134
782 Added 72.21%
1,865 $4,000
Q4 2023

Feb 01, 2024

BUY
$0.38 - $0.91 $164 - $394
433 Added 66.62%
1,083 $1,000
Q2 2022

Jul 28, 2022

SELL
$7.94 - $12.96 $71 - $116
-9 Reduced 1.37%
650 $7,000
Q4 2021

Jan 31, 2022

BUY
$9.93 - $15.39 $89 - $138
9 Added 1.38%
659 $9,000
Q3 2020

Sep 15, 2021

BUY
$40.47 - $45.5 $26,305 - $29,575
650 New
650 $17,000
Q3 2020

Oct 19, 2020

SELL
$40.47 - $45.5 $26,305 - $29,575
-650 Closed
0 $0
Q2 2020

Sep 15, 2021

BUY
$32.57 - $42.83 $21,170 - $27,839
650 New
650 $17,000
Q2 2020

Jul 22, 2020

SELL
$32.57 - $42.83 $21,170 - $27,839
-650 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$23.3 - $45.96 $15,145 - $29,874
650 New
650 $17,000
Q1 2020

Apr 28, 2020

SELL
$23.3 - $45.96 $15,145 - $29,874
-650 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$34.58 - $48.06 $20,713 - $28,787
599 Added 1174.51%
650 $17,000
Q4 2019

Jan 27, 2020

SELL
$34.58 - $48.06 $20,713 - $28,787
-599 Reduced 92.15%
51 $2,000
Q3 2019

Sep 14, 2021

BUY
$36.98 - $48.45 $24,036 - $31,492
650 New
650 $17,000
Q3 2019

Oct 22, 2019

SELL
$36.98 - $48.45 $24,036 - $31,492
-650 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$35.13 - $55.53 $22,834 - $36,094
650 New
650 $17,000
Q2 2019

Jul 31, 2019

SELL
$35.13 - $55.53 $22,834 - $36,094
-650 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$42.83 - $59.91 $27,839 - $38,941
650 New
650 $0

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.